The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma.
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.
Lung cancer survivor Amanda Nerstad shares what it was like receiving a stage 4 diagnosis at age 39, the role genomic testing played in prolonging her quality of life, and how she and her family cope with the diagnosis.
Read research from the March 2022 session of the ASCO Plenary Series, which highlights an immunotherapy combination to treat advanced melanoma and adding immunotherapy to chemotherapy to treat advanced non-small cell lung cancer.
In this podcast, Dr. Funda Meric-Bernstam and Dr. Mark Robson discuss a new ASCO provisional clinical opinion on somatic genomic testing in people with metastatic or advanced cancer, including what it is and how it impacts cancer treatment.
Read research from the February 2022 session of the ASCO Plenary Series, which highlights a study on daily aspirin to prevent breast cancer recurrence and another on using targeted therapy to treat advanced pancreatic cancer with a specific mutation.
Read research from the January 2022 session of the ASCO Plenary Series, which highlights a study comparing 2 targeted therapies in treating advanced gastrointestinal stromal tumors (GISTs).
Colorectal cancer survivor Danielle Ripley-Burgess shares what it was like being diagnosed with colorectal cancer twice, at ages 17 and 25, and how she navigated coping with her diagnosis as a teen and young adult.
Stage IV lung cancer survivor Frank Sierawski shares what it was like being diagnosed with cancer at age 35 and how he learned to cope with the diagnosis by living in the moment.
Research from the first ASCO Plenary Series presentation has arrived. Read more about studies on using immunotherapy to treat metastatic melanoma and how technology can be used to find and manage symptoms during cancer treatment.
